Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVersarien Regulatory News (VRS)

  • This share is currently suspended. It was suspended at a price of 0.01
  • There is currently no data for VRS

Directorate Changes

18 Jul 2023 16:31

RNS Number : 4187G
Versarien PLC
18 July 2023
 

18 July 2023

 

Versarien plc

 

("Versarien" or the "Company")

 

Directorate Changes

 

Versarien plc (AIM: VRS), the advanced materials engineering group, is pleased to announce the appointment of Dr Stephen Hodge, currently the Company's Chief Technology Officer, as the Company's Chief Executive Officer with immediate effect.

 

Dr Stephen Hodge joined Versarien in 2017 and was appointed Head of Research in July 2018, before being appointed to the Board as Chief Technology Officer in January 2021. Prior to this, he was employed as a Principal Engineer at Cambridge Graphene Limited, a supplier of graphene inks and other graphene materials, and a subsidiary of Versarien. He has also held post-doctoral research associate positions at the Cambridge Graphene Centre, a research centre attached to the Department of Engineering at the University of Cambridge, and in the Department of Chemistry at Imperial College London, where he also completed a PhD in Nanomaterial Chemistry.

 

Stephen is a member of a number of advisory boards including holding the role of Chairman of the Technical Working Group within the Graphene REACH registration consortium. Last year Dr Hodge was awarded the Royal Society of Chemistry Rising Star in Industry Award 'for strategic leadership in developing greener solutions and advocating for global regulations related to the physical and toxicological testing of graphene'.

 

Resignation of Director

 

The Company has today received confirmation that Neill Ricketts has resigned from the Board with effect from 14 July 2023 and is no longer a Director of the Company. He continues on garden leave with no day-to-day responsibilities unless required by the Company.

 

Diane Savory, Non-executive Chair of Versarien, commented:

 

"I am very pleased that we are announcing the appointment of Stephen Hodge as Versarien's Chief Executive Officer. Stephen has been with Versarien for the past six years during which time he has been instrumental in the development of the Company's advanced materials technology and progressing our commercial relationships. I believe he is ideally placed to lead the Company as we continue to progress our turnaround strategy and focus on the development and commercialisation of Cementene™ and Graphene-Wear™.

 

"On behalf of the Board I would like to thank Neill Ricketts for his contribution to the Company since its formation and we wish him well in his future endeavours.

 

"We look forward to updating shareholders on the continuing progress with our turnaround strategy in the coming months."

 

For further information please contact:

 

Versarien

Stephen Hodge, Chief Executive Officer

Chris Leigh, Chief Financial Officer

c/o IFC

SP Angel Corporate Finance (Nominated Adviser and Broker)

Matthew Johnson, Adam Cowl

+44 (0)20 3470 0470

 

 

IFC Advisory Limited (Financial PR and Investor Relations)

Tim Metcalfe, Zach Cohen

+44 (0) 20 3934 6630

 

About Versarien:

 

The strategy of Versarien plc (AIM:VRS) is to be a development led advanced materials company focussed on specific sectors that will lead to a light manufacturing and licensing model.

 

For further information please see: http://www.versarien.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOANKFBBPBKDFOD
Date   Source Headline
25th Sep 20187:00 amRNSAcquisition of Gnanomat S.L.
24th Sep 20187:00 amRNSSuccessful Fundraising of £5.2m via PrimaryBid
21st Sep 20184:57 pmRNSPrimaryBid.com Offer
30th Aug 20187:00 amRNSAward of Share Options to Directors
29th Aug 20189:40 amRNSVersarien joins "Exporting is GREAT Campaign"
24th Aug 20187:00 amRNSConstruction Materials Collaboration
21st Aug 20187:00 amRNSNotice of AGM and posting of Annual Report
20th Aug 20187:00 amRNSCollaboration Agreement with AXIA Materials
15th Aug 20187:00 amRNSAppointment of further DIT secondee
2nd Aug 20187:00 amRNSSporting Goods Collaboration
31st Jul 20187:00 amRNSHolding(s) in Company
20th Jul 20187:00 amRNSGraphene Quality Assurance
19th Jul 20187:00 amRNSPreliminary Results
16th Jul 20187:00 amRNSAppointment of Head of Research
6th Jul 20187:00 amRNSNotice of Results
2nd Jul 20187:00 amRNSBattery Technology Update
25th Jun 20187:00 amRNSVersarien joins the GEIC
18th Jun 20187:00 amRNSCommercial Agreement with MediaDevil
12th Jun 20187:00 amRNSDirector/PDMR Shareholding
8th Jun 201811:00 amRNSPrice Monitoring Extension
8th Jun 20187:01 amRNSAgreement with Arrow GreenTech
8th Jun 20187:00 amRNSGraphinks Product Launch
7th Jun 20182:05 pmRNSSecond Price Monitoring Extn
7th Jun 20182:00 pmRNSPrice Monitoring Extension
7th Jun 20187:00 amRNSVersarien appointed to NGA Industry Council
29th May 20187:00 amRNSConsumer Goods Collaboration
22nd May 20187:00 amRNSAppointment of senior DIT secondee
4th May 20187:00 amRNSChange of Nominated Adviser and Broker
30th Apr 20187:00 amRNSAgreement with Luxus
16th Apr 20187:25 amRNSGraphene Supply to Major Tyre Producer
3rd Apr 20181:32 pmRNSHolding(s) in Company
28th Mar 20187:00 amRNSHexotene Product Launch
27th Mar 20187:00 amRNSCollaboration with World Leading Aerospace Group
14th Mar 20187:00 amRNSCollaboration with Team Sky
7th Mar 20181:15 pmRNSAdditional Investor Event
7th Mar 20187:00 amRNSInvestor Event
27th Feb 20184:41 pmRNSSecond Price Monitoring Extn
27th Feb 20184:35 pmRNSPrice Monitoring Extension
27th Feb 20187:00 amRNSAgreement with Vivobarefoot
21st Feb 20187:00 amRNSMedical Technology Collaboration
5th Feb 20187:00 amRNSAppointment to US National Graphene Advisory Board
2nd Feb 20184:40 pmRNSHolding(s) in Company
29th Jan 20183:18 pmRNSExercise of Options
23rd Jan 20183:33 pmRNSHolding(s) in Company
15th Jan 20182:05 pmRNSSecond Price Monitoring Extn
15th Jan 20182:00 pmRNSPrice Monitoring Extension
15th Jan 201811:05 amRNSSecond Price Monitoring Extn
15th Jan 201811:00 amRNSPrice Monitoring Extension
15th Jan 20189:05 amRNSSecond Price Monitoring Extn
15th Jan 20189:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.